FDA Clearance Tracker · P000027-S005
ELECSYS FREE PSA IMMUNOASSAY, PSA CALSET & PSA CALCHECK
Last checked: Nov 20, 2026Latest source record: Mar 3, 2009 (this decision)Source: openFDAMethods & limitations
Decided
Mar 3, 2009
Approved
Time to decision
589 days
Received Jul 23, 2007. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P000027-S005
- Device name
- ELECSYS FREE PSA IMMUNOASSAY, PSA CALSET & PSA CALCHECK
- Applicant
- Roche Diagnostics Corp.
- Applicant location
- Indianapolis, IN
- Received
- Jul 23, 2007
- Decided
- Mar 3, 2009
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P000027
Device type
- Device class
- Class III
- Specialty
- Laboratory Medicine & Pathology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR EXTENSION OF THE ELECSYS TOTAL PSA SYSTEM ONTO AN UPDATED MODEL OF THE MODULAR ANALYTICS E170 ANALYZER, KNOWN AS THE COBAS E411 ANALYZER.
Source documents
Other decisions for Roche Diagnostics Corp.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.